People
-
Arikace developer Insmed Incorporated has appointed Will Lewis, co-founder of Aegerion Pharmaceuticals, to succeed Tim Whitten as President and Chief Executive Officer. According to the company, Whitten has resigned from the board of directors as… Read more . . .
-
Civitas Therapeutics has appointed Bryan Stuart as Chief Business Officer. Civitas, which was spun off from Alkermes, is developing carrier-free inhaled drugs based on its ARCUS particle engineering platform and inhaler. The company’s lead candidate… Read more . . .
-
Pulmatrix has announced that Robert Clarke will succeed Robert Connelly as the company’s Chief Executive Officer. Clarke has been with the company, which is developing inhaled drugs based on its proprietary iSPERSE (inhaled small particles… Read more . . .
-
Hovione has named Mike Ironside as General Manager of its Technology Transfer Center (TTC), which is located in New Jersey. Ironside was most recently with Anacor Pharmaceuticals and has previously worked for GSK and AMRI.… Read more . . .
-
Particle manufacturing specialist Liquidia Technologies has named Benjamin Yerxa, most recently at Clearside Biomedical, as its new Chief Scientific Officer. Yerxa will oversee R&D, “including a focus on scientific collaborations,” for the company. Liquidia’s PRINT… Read more . . .
-
Hovione has announced the appointment of Conrad Winters as Director, Drug Product Development. Winters most recently was Senior Director of the Compound Properties Group at Xenon Pharmaceuticals and previously held positions with Merck. Hovione VP… Read more . . .
-
Inhaled drug company Alexza Pharmaceuticals has announced the promotions of four executives. The company has promoted James V. Cassella to Executive VP, Research and Development and Chief Scientific Officer; Darl Moreland to Senior VP, Quality;… Read more . . .
-
Indian pharmaceutical company Cipla has hired former Teva vice-president Frank Pieters as Head of European Business and Head of Global Respiratory Business. Pieters was most recently Senior VP for the Region of Southern Europe at… Read more . . .
-
Insmed Incorporated, which is developing Arikace liposomal amikacin for inhalation, has appointed Donald J. Hayden, Jr. as Executive Chairman of its Board of Directors, effective immediately. He has been serving as Chairman of the board… Read more . . .
-
Mark Shepherd, Respiratory Physics Lab and Workshop Manager at Team Consulting, will attempt to set a world record by climbing to the top of the Empire State Building in New York City while carrying 125… Read more . . .
Featured event:

Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
October 28-October 30: Deutches Aerosol Therapie Symposium (DATS), Marburg, Germany
November 10-November 11: Rescon Europe 2026, Porto, Portugal



